Viewing Study NCT03927157


Ignite Creation Date: 2025-12-24 @ 6:59 PM
Ignite Modification Date: 2026-02-24 @ 10:52 AM
Study NCT ID: NCT03927157
Status: COMPLETED
Last Update Posted: 2025-07-01
First Post: 2019-04-23
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Evaluate Tezepelumab in Adults With Severe Uncontrolled Asthma
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Asthma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Asthma View
None Uncontrolled Asthma View
None Severe Uncontrolled Asthma View